{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:49:49Z","timestamp":1781045389240,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajpath.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T02:21:45Z","timestamp":1587694905000},"page":"1752-1762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-6246","authenticated-orcid":false,"given":"Norihiko","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiyu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-2816","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2020.04.005_bib1","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2020.04.005_bib2","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2020.04.005_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2020.04.005_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2020.04.005_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2020.04.005_bib6","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.005_bib7","doi-asserted-by":"crossref","first-page":"244ra91","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2020.04.005_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2020.04.005_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41598-018-22126-x","article-title":"A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort","volume":"8","author":"Marzouka","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2020.04.005_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnci\/djx243","article-title":"Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas","volume":"110","author":"Mo","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2020.04.005_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","article-title":"Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors","volume":"75","author":"Tan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urolonc.2007.07.010","article-title":"The impact of variant histology on the outcome of bladder cancer treated with curative intent","volume":"27","author":"Black","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib13","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1016\/j.clgc.2017.07.008","article-title":"Squamous differentiation predicts poor response to cisplatin-based chemotherapy and unfavorable prognosis in urothelial carcinoma of the urinary bladder","volume":"15","author":"Minato","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ajpath.2020.04.005_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2020.04.005_bib15","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/0008-5472.CAN-18-0173","article-title":"Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy","volume":"78","author":"Saito","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib16","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","article-title":"A carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer","volume":"37","author":"Fantini","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2020.04.005_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1101\/gad.1772909","article-title":"Inactivation of p53 and Pten promotes invasive bladder cancer","volume":"23","author":"Puzio-Kuter","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2020.04.005_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/0008-5472.CAN-16-2621","article-title":"ARF confers a context-dependent response to chemotherapy in muscle-invasive bladder cancer","volume":"77","author":"Owczarek","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/carcin\/bgr137","article-title":"Thioredoxin-interacting protein suppresses bladder carcinogenesis","volume":"32","author":"Nishizawa","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2020.04.005_bib20","first-page":"727","article-title":"Review: BBN as an urothelial carcinogen","volume":"26","author":"Vasconcelos-Nobrega","year":"2012","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ajpath.2020.04.005_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccell.2014.09.001","article-title":"Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors","volume":"26","author":"Shin","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2020.04.005_bib22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/ncb3038","article-title":"Bladder cancers arise from distinct urothelial sub-populations","volume":"16","author":"Van Batavia","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib23","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1073\/pnas.94.14.7400","article-title":"Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development","volume":"94","author":"Tarutani","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.005_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/eji.200636745","article-title":"Faithful activation of an extra-bright red fluorescent protein in \u201cknock-in\u201d Cre-reporter mice ideally suited for lineage tracing studies","volume":"37","author":"Luche","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2020.04.005_bib26","doi-asserted-by":"crossref","first-page":"e35243","DOI":"10.1371\/journal.pone.0035243","article-title":"A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2020.04.005_bib27","first-page":"2053","article-title":"Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor","volume":"6","author":"Ciardiello","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000358640","article-title":"Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model","volume":"33","author":"Liu","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajpath.2020.04.005_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1414s49","article-title":"Mouse models of human bladder cancer as a tool for drug discovery","author":"Seager","year":"2010","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib30","series-title":"R, A Language and Environment for Statistical Computing","year":"2009"},{"key":"10.1016\/j.ajpath.2020.04.005_bib31","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib32","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gky1056","article-title":"Mouse genome database (MGD) 2019","volume":"47","author":"Bult","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib33","series-title":"Algorithms for Clustering Data","author":"Jain","year":"1988"},{"key":"10.1016\/j.ajpath.2020.04.005_bib34","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.005_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2020.04.005_bib36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/onc.2012.101","article-title":"Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer","volume":"32","author":"Saito","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2020.04.005_bib37","doi-asserted-by":"crossref","first-page":"38531","DOI":"10.1038\/srep38531","article-title":"FOXA1, GATA3 and PPAR cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines","volume":"6","author":"Warrick","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2020.04.005_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","article-title":"Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy","volume":"72","author":"Seiler","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib40","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-18-1106","article-title":"Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer","volume":"25","author":"Seiler","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2020.04.005_bib41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/iju.14082","article-title":"Predictive biomarkers for drug response in bladder cancer","volume":"26","author":"Yoshida","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajpath.2020.04.005_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/onc.2016.172","article-title":"Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response","volume":"36","author":"Nickerson","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2020.04.005_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.devcel.2013.07.017","article-title":"Retinoid signaling in progenitors controls specification and regeneration of the urothelium","volume":"26","author":"Gandhi","year":"2013","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2020.04.005_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/stem.92","article-title":"Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma","volume":"27","author":"He","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.ajpath.2020.04.005_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","article-title":"Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants","volume":"75","author":"Warrick","year":"2019","journal-title":"Eur Urol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020302029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020302029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:36:42Z","timestamp":1757695002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944020302029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0002944020302029"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.005","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}